Cargando…

Part I of GANNET53: A European Multicenter Phase I/II Trial of the Hsp90 Inhibitor Ganetespib Combined With Weekly Paclitaxel in Women With High-Grade, Platinum-Resistant Epithelial Ovarian Cancer—A Study of the GANNET53 Consortium

Background: Stabilized mutant p53 protein (mutp53) is a novel target in epithelial ovarian cancer. Due to aberrant conformation, mutp53 proteins depend on folding support by the Hsp90 chaperone. Hsp90 blockade induces degradation of mutp53, resulting in tumor cell cytotoxicity and increased sensitiv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ray-Coquard, Isabelle, Braicu, Ioana, Berger, Regina, Mahner, Sven, Sehouli, Jalid, Pujade-Lauraine, Eric, Cassier, Philippe Alexandre, Moll, Ute Martha, Ulmer, Hanno, Leunen, Karin, Zeimet, Alain Gustave, Marth, Christian, Vergote, Ignace, Concin, Nicole
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746955/ https://www.ncbi.nlm.nih.gov/pubmed/31552170 http://dx.doi.org/10.3389/fonc.2019.00832

Ejemplares similares

Habitat-specific foraging strategies in Australasian gannets
por: Wells, Melanie R., et al.
Publicado: (2016)

Sexual Size Dimorphism and Body Condition in the Australasian Gannet
por: Angel, Lauren P., et al.
Publicado: (2015)

Δ133p53 is an independent prognostic marker in p53 mutant advanced serous ovarian cancer
por: Hofstetter, G, et al.
Publicado: (2011)

Excess Baggage for Birds: Inappropriate Placement of Tags on Gannets Changes Flight Patterns
por: Vandenabeele, Sylvie P., et al.
Publicado: (2014)

Eating locally: Australasian gannets increase their foraging effort in a restricted range
por: Angel, Lauren P., et al.
Publicado: (2015)

Changes in behaviour drive inter-annual variability in the at-sea distribution of northern gannets
por: Warwick-Evans, V., et al.
Publicado: (2016)

Geographical, temporal and individual factors influencing foraging behaviour and consistency in Australasian gannets
por: Rodríguez-Malagón, Marlenne A., et al.
Publicado: (2020)

Factors influencing prey capture success and profitability in Australasian gannets (Morus serrator)
por: Cansse, Thomas, et al.
Publicado: (2020)

Handedness and individual roll-angle specialism when plunge diving in the northern gannet
por: Bennison, Ashley, et al.
Publicado: (2023)

Radar detectors carried by Cape gannets reveal surprisingly few fishing vessel encounters
por: Grémillet, David, et al.
Publicado: (2019)

Evidence of links between haematological condition and foraging behaviour in northern gannets (Morus bassanus)
por: Malvat, Z., et al.
Publicado: (2020)

Factors that influence Cape fur seal predation on Cape gannets at Lambert’s Bay, South Africa
por: Strydom, Zanri, et al.
Publicado: (2022)

Estimated mortality of the highly pathogenic avian influenza pandemic on northern gannets (Morus bassanus) in southwest Ireland
por: Giralt Paradell, Oriol, et al.
Publicado: (2023)

The effectiveness of regulatory signs in controlling human behaviour and Northern gannet (Morus bassanus) disturbance during breeding: an experimental test
por: Allbrook, Debs L., et al.
Publicado: (2020)

Quantifying inter-annual variability on the space-use of parental Northern Gannets (Morus bassanus) in pursuit of different prey types
por: d’Entremont, Kyle J. N., et al.
Publicado: (2023)

Under pressure—exploring partner changes, physiological responses and telomere dynamics in northern gannets across varying breeding conditions
por: Pelletier, David, et al.
Publicado: (2023)

Treatment reality in elderly patients with advanced ovarian cancer: a prospective analysis of the OVCAD consortium
por: Trillsch, Fabian, et al.
Publicado: (2013)

HIF1α is an independent prognostic factor for overall survival in advanced primary epithelial ovarian cancer – a study of the OVCAD Consortium
por: Braicu, Elena Ioana, et al.
Publicado: (2014)

The Long-Term Prognostic Significance of Circulating Tumor Cells in Ovarian Cancer—A Study of the OVCAD Consortium
por: Obermayr, Eva, et al.
Publicado: (2021)

Oiling of American white pelicans, common loons, and northern gannets in the winter following the Deepwater Horizon (MC252) oil spill
por: Paruk, J. D., et al.
Publicado: (2020)

Association of a Combined Cancer Exhaustion Score with Circulating Tumor Cells and Outcome in Ovarian Cancer—A Study of the OVCAD Consortium
por: Obermayr, Eva, et al.
Publicado: (2021)

Definition and Independent Validation of a Proteomic-Classifier in Ovarian Cancer
por: Kasimir-Bauer, Sabine, et al.
Publicado: (2020)

Ganetespib synergizes with cyclophosphamide to improve survival of mice with autochthonous tumors in a mutant p53-dependent manner
por: Alexandrova, Evguenia M, et al.
Publicado: (2017)

Biomarker-Based Models for Preoperative Assessment of Adnexal Mass: A Multicenter Validation Study
por: Watrowski, Rafał, et al.
Publicado: (2022)

Clinical significance of the estrogen-modifying enzymes steroid sulfatase and estrogen sulfotransferase in epithelial ovarian cancer
por: Mungenast, Felicitas, et al.
Publicado: (2017)

Normalized LST Is an Efficient Biomarker for Homologous Recombination Deficiency and Olaparib Response in Ovarian Carcinoma
por: Christinat, Yann, et al.
Publicado: (2023)

A comparison of four technologies for detecting p53 aggregates in ovarian cancer
por: Heinzl, Nicole, et al.
Publicado: (2022)

A combined blood based gene expression and plasma protein abundance signature for diagnosis of epithelial ovarian cancer - a study of the OVCAD consortium
por: Pils, Dietmar, et al.
Publicado: (2013)

Preoperative HE4 and ROMA values do not improve the CA125 diagnostic value for borderline tumors of the ovary (BOT) – a study of the TOC Consortium
por: Braicu, Elena Ioana, et al.
Publicado: (2014)

Clinical Significance of Organic Anion Transporting Polypeptide Gene Expression in High-Grade Serous Ovarian Cancer
por: Svoboda, Martin, et al.
Publicado: (2018)

Ambivalent role of pFAK-Y397 in serous ovarian cancer-a study of the OVCAD consortium
por: Aust, Stefanie, et al.
Publicado: (2014)

Circulating tumor cells: potential markers of minimal residual disease in ovarian cancer? a study of the OVCAD consortium
por: Obermayr, Eva, et al.
Publicado: (2017)

A Phase I Study of Ganetespib and Ziv‐Aflibercept in Patients with Advanced Carcinomas and Sarcomas
por: Meehan, Robert, et al.
Publicado: (2018)

Ganetespib: research and clinical development
por: Jhaveri, Komal, et al.
Publicado: (2015)

Fertility-Sparing Surgery in Early Epithelial Ovarian Cancer: A Viable Option?
por: Fotopoulou, Christina, et al.
Publicado: (2012)

Evaluation of folate receptor 1 (FOLR1) mRNA expression, its specific promoter methylation and global DNA hypomethylation in type I and type II ovarian cancers
por: Notaro, Sara, et al.
Publicado: (2016)

Ganetespib radiosensitization for liver cancer therapy
por: Chettiar, Sivarajan T., et al.
Publicado: (2016)

Prognostic impact of tumor infiltrating CD8+ T cells in association with cell proliferation in ovarian cancer patients - a study of the OVCAD consortium
por: Bachmayr-Heyda, Anna, et al.
Publicado: (2013)

Detection of soluble EpCAM (sEpCAM) in malignant ascites predicts poor overall survival in patients treated with catumaxomab
por: Seeber, Andreas, et al.
Publicado: (2015)

AID/APOBEC-network reconstruction identifies pathways associated with survival in ovarian cancer
por: Svoboda, Martin, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_km49nr8ah1i3hq24luhq92vk6q